Hepatitis B Surface Antigens
"Hepatitis B Surface Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
| Descriptor ID |
D006514
|
| MeSH Number(s) |
D23.050.327.495.500.475
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B Surface Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B Surface Antigens".
This graph shows the total number of publications written about "Hepatitis B Surface Antigens" by people in this website by year, and whether "Hepatitis B Surface Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 2 | 3 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 2 | 4 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 3 | 4 |
| 2017 | 30 | 44 | 74 |
| 2018 | 25 | 37 | 62 |
| 2019 | 3 | 28 | 31 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis B Surface Antigens" by people in Profiles.
-
Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacy. Hum Vaccin Immunother. 2021 11 02; 17(11):4578-4586.
-
Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination. Vaccine. 2021 09 15; 39(39):5666-5672.
-
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19. Hepatology. 2021 10; 74(4):1750-1765.
-
A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation. Front Immunol. 2021; 12:637654.
-
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment. Dig Dis Sci. 2021 11; 66(11):4026-4034.
-
Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy. J Viral Hepat. 2021 01; 28(1):89-94.
-
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. Am J Clin Dermatol. 2019 Dec; 20(6):829-845.
-
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort. J Antimicrob Chemother. 2019 11 01; 74(11):3295-3304.
-
Occult hepatitis B and HIV infection. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1403-1407.
-
Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response. Front Immunol. 2019; 10:2308.